Clinical Trial Update: Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating multivirus-specific T cells for refractory CMV and/or EBV infection after allo-HSCT.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cmv Infection
• Ebv Infection

Drugs mentioned

• multivirus-specific T cells

Snippet

Sponsor: Peking University People's Hospital | Conditions: CMV Infection, EBV Infection | Phase 1, Phase 2 | Status: UNKNOWN